Results: 52

Aumento aislado y sostenido de aspartato aminotransferasa por presencia de macroenzimas: caso clínico

Rev. méd. Chile; 144 (8), 2016
We report an asymptomatic 23-year-old woman with an isolated and persistent increase in serum levels of aspartate aminotransferase (AST). An extensive work up including laboratory and image testing revealed no abnormalities thus suggesting the presence of macro-AST. A polyethylene glycol (PEG) precipitat...

Clinical and laboratory characteristics of patients with thyroid diseases with and without alanine aminotransferase levels above the upper tertile – Cross-sectional analytical study

Objective Thyroid disease affects 6.6% of the general population. The liver is fundamental in metabolizing thyroid hormones, and hepatocytes are often affected in thyroid disease. We aimed to compare clinical and laboratory parameters among thyroid disease patients with alanine aminotransferase (ALT) le...

Hepato-protective effect of rutin via IL-6/STAT3 pathway in CCl4-induced hepatotoxicity in rats

Biol. Res; 48 (), 2015
BACKGROUND: Carbon tetrachloride (CCl4) induces hepatotoxicity in animal models, including the increased blood flow and cytokine accumulation that are characteristic of tissue inflammation. The present study investigates the hepato-protective effect of rutin on CCl4-induced hepatotoxicity in rats. RESULT...

Overweight and Obesity in Southern Italy: their association with social and life-style characteristics and their effect on levels of biologic markers
Overweight and Obesity in Southern Italy: their association with social and life-style characteristics and their effect on levels of biologic markers.

BACKGROUND: In the last decades, overweight and obesity have been transformed from minor public health issues to a major threat to public health affecting the most affluent societies and also the less developed ones. OBJECTIVES: To estimate overweight-obesity prevalence in adults, their association with ...

Alpha-Interferon therapy for HBV-related glomerulonephritis

Säo Paulo med. j; 116 (5), 1998
We report a case of a patient with hepatitis B virus (HBV)-related membranous glomerulonephritis (MGN) who showed improvement after interferon-alpha (IFN-alpha) therapy. A 35-year-old man with nephrotic syndrome and HBV antigens received a 24-week course of IFN-alpha. At the end of therapy there was an e...

Interferon alfa recombinante no tratamento da hepatite C crônica
Recombinant alfa interferon in the treatment of chronic hepatitis C

Introduçao. A hepatite crônica pelo vírus C apresenta tendência evolutiva para cirrose hepática e hepatocarcinoma. Tratamento, com drogas antivirais, está indicado numa tentativa de modificar a evoluçao da doença. Objetivo. Avaliar a resposta de pacientes com hepatite crônica ou cirrose pós-hep...

Supraceliac clamping in the surgical treatment of abdominal aortic aneurysm: an experimental study in dogs

Säo Paulo med. j; 112 (2), 1994
Trabalhos anteriores sugerem a oclusäo supra-celíaca no tratamento cirúrgico dos aneurismas da aorta abdominal de dificil abordagem. Com o objetivo de estudar as repercussöes metabólicas hepáticas e renais, três grupos de cäes foram submetidos à oclusäo temporária (30 minutos) da aorta abdomin...

Prevalencia de anticuerpos contra el virus de la hepatitis C y otros marcadores virales en donantes de sangre voluntários de la Cruz Roja HYondureña
Prevalence of Hepatitis C virus and other virals markers in volunteer blood donors of the Cruz Roja Hondureña

Rev. méd. hondur; 58 (3), 1990
Se evaluaron 973 donantes voluntarios del Centro Nacional de Sangre en Tegucigalpa, por la presencia de anticuerpos contra el virus de la Hepatitis C (Anti-VHC); anticuerpos contra el núcleo del virus de la Hepatitis B (Anti-HBc), contra el antígeno de superficie (Anti-HBc), contra el Antígeno de Supe...

Sinvastatina (MK-733), novo inibidor da HMG-CoA redutase no tratamento da hipercolesterolemia do idoso com doença aterosclerótica

Arq. bras. cardiol; 54 (6), 1990
Objetivo: Avaliação da eficácia e tolerabilidade da sinvastatina, um novo e potente inibidor da HMGCoA redutase, no tratamento da hipercolesterolemia em pacientes idosos. Casuística e Métodos: Foram estudados 20 pacientes com idades entre 65 e 72 anos (x = 69 ± 3), sendo 14 mulheres e 6 homens, com...